July 2 (Reuters) - Strativa Pharmaceutical:
* FDA approves Strativa Pharmaceuticals' Zuplenz (Ondansetron) oral soluble
film
* Strativa pharmaceuticals says Zuplenz to be available in retail pharmacies in
the third quarter of 2010
* Strativa says FDA approval triggered co's payments to MonoSol of $4 million
approval milestone and $2.0 million pre-launch milestone
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* FDA approves Strativa Pharmaceuticals' Zuplenz (Ondansetron) oral soluble
film
* Strativa pharmaceuticals says Zuplenz to be available in retail pharmacies in
the third quarter of 2010
* Strativa says FDA approval triggered co's payments to MonoSol of $4 million
approval milestone and $2.0 million pre-launch milestone
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.